19
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Theoretical investigation of favipiravir antiviral drug based on fullerene and boron nitride nanocages

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Smart implementation of novel advanced nanocarriers such as functionalized C 24 and B 12N 12 nanocages is used supplement for antiviral activity 5-Fluoro-2-hydroxypyrazine-3-carboxamide (Favipiravir; Avigan; T-705), as treatment of COVID-19. The interaction energies of Favipiravir with perfect (B 12N 12 and C 24) and doped (BC 23 and CB 11N 12) nanocages were studied at temperatures equal to 310.15 K and 298.15 K using DFT. Our results have shown that the interaction of the Favipiravir (C [Private characterE00C ] O group) with BC 23 and CB 11N 12 is more favorable than with the C 24 and B 12N 12 nanocages in the gas and aqueous environments.

          Additionally, the natural bond orbital, the highest occupied molecular orbital (HOMO), the lowest unoccupied molecular orbital (LUMO), energy gap, chemical reactivity, molecular electrostatic potential, and thermodynamic parameters of the optimized structure have been examined. Furthermore, the UV–Vis and infrared spectroscopy have been evaluated for the investigation of the molecular orbitals Participated in the absorption spectrum of the Favipiravir before and after the interaction with the C 24, BC 23, B 12N 12, and CB 11N 12, sites at maximum wavelength utilizing the time-dependent density functional theory (TD-B3LYP and TD-CAM-B3LYP). The intermolecular interactions have been analyzed by non-covalent interactions (NCI) and also, the electron localization function (ELF) is discussed.

          Graphical abstract

          Related collections

          Most cited references43

          • Record: found
          • Abstract: not found
          • Article: not found

          A new hybrid exchange–correlation functional using the Coulomb-attenuating method (CAM-B3LYP)

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro

            Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 hours post infection with SARS-CoV-2 able to effect ∼5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              A simple measure of electron localization in atomic and molecular systems

                Bookmark

                Author and article information

                Journal
                Diam Relat Mater
                Diam Relat Mater
                Diamond and Related Materials
                Published by Elsevier B.V.
                0925-9635
                0925-9635
                15 May 2021
                15 May 2021
                : 108458
                Affiliations
                [a ]Department of Chemistry, Faculty of Science, Benha University, P.O. Box 13518, Benha, Egypt
                [b ]Department of Chemistry, College of Science, Qassim University, Kingdom of Saudia Arabia
                Author notes
                [* ]Corresponding author at: Department of Chemistry, Faculty of Science, Benha University, P.O. Box 13518, Benha, Egypt
                Article
                S0925-9635(21)00221-1 108458
                10.1016/j.diamond.2021.108458
                8123382
                34025036
                af84b9d2-f689-44fb-b416-0a6c22439b6b
                © 2021 Published by Elsevier B.V.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 17 March 2021
                : 22 April 2021
                : 9 May 2021
                Categories
                Article

                dft calculations,favipiravir,drug delivery,c24, b12n12, bc23, and cb11n12 nanocages

                Comments

                Comment on this article